The Harvard spinout has raised a second funding round that included existing shareholder Cedars-Sinai, boosting its total equity funding to $40m.
Emulate, a US-based biotechnology spinout of Harvard University’s Wyss Institute, raised $28m in a series B round backed by hospital Cedars-Sinai Medical Center on Monday.
NanoDimension, OS Fund, Atel Ventures, Leandro P Rizzuto Foundation’s ALS Finding a Cure program, private investor Hansjörg Wyss and an additional, unnamed investor also participated in the round.
Founded in 2013, Emulate is developing organs-on-chips technology. The chips are the size of small batteries and contain tens of thousands of living human cells…
